Charles Schwab Investment Management Inc Dexcom Inc Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,330,302 shares of DXCM stock, worth $264 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,330,302

Previous 2,241,701 3.95%

Holding current value

$264 Million

Previous $278 Million 16.19%

% of portfolio

0.08%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $10.1 Million - $12.4 Million	88,601 Added 3.95%	2,330,302 $323 Million
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $6.1 Million - $10 Million	80,740 Added 3.74%	2,241,701 $278 Million
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $2.46 Million - $3.95 Million	28,621 Added 1.34%	2,160,961 $202 Million
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $2.77 Million - $3.22 Million	24,599 Added 1.17%	2,132,340 $274 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $3.56 Million - $4.2 Million	34,199 Added 1.65%	2,107,741 $245 Million

Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $3.31 Million - $4.78 Million	38,958 Added 1.91%	2,073,542 $235 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $3.56 Million - $4.39 Million	46,651 Added 2.35%	2,034,584 $164 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $102 Million - $200 Million	1,506,689 Added 313.08%	1,987,933 $148 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $1.25 Million - $1.74 Million	13,338 Added 2.85%	481,244 $246 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $1.55 Million - $1.94 Million	11,943 Added 2.62%	467,906 $251 Million
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $905,007 - $1.21 Million	8,481 Added 1.9%	455,963 $249 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.41 Million - $1.87 Million	17,363 Added 4.04%	447,482 $191 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $549,100 - $678,296	6,476 Added 1.53%	430,119 $155 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $1.06 Million - $1.42 Million	-13,544 Reduced 3.1%	423,643 $157 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $2.63 Million - $3.11 Million	27,517 Added 6.72%	437,187 $180 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $10.4 Million - $17.4 Million	165,531 Added 67.8%	409,670 $166 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $143,847 - $227,646	-3,010 Reduced 1.22%	244,139 $65.7 Million
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $97,335 - $152,276	-2,658 Reduced 1.06%	247,149 $54.1 Million
Q3 2019 Nov 08, 2019	SELL	$35.53 - $43.8 $6.72 Million - $8.29 Million	-189,189 Reduced 43.1%	249,807 $37.3 Million
Q2 2019 Aug 09, 2019	BUY	$27.84 - $38.92 $374,392 - $523,396	13,448 Added 3.16%	438,996 $65.8 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $1.98 Million - $2.69 Million	70,570 Added 19.88%	425,548 $50.7 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $453,458 - $627,853	16,801 Added 4.97%	354,978 $42.5 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $458,383 - $720,850	19,631 Added 6.16%	338,177 $48.4 Million
Q2 2018 Aug 08, 2018	BUY	$17.54 - $25.22 $408,489 - $587,348	23,289 Added 7.89%	318,546 $30.3 Million
Q1 2018 May 07, 2018	BUY	$13.06 - $18.54 $424,358 - $602,420	32,493 Added 12.37%	295,257 $21.9 Million
Q4 2017 Jan 17, 2018	SELL	$11.12 - $15.38 $25,075 - $34,681	-2,255 Reduced 0.85%	262,764 $15.1 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $3.01 Million - $5.03 Million	265,019	265,019 $13 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Dexcom Inc Transaction History